JP2011514355A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011514355A5 JP2011514355A5 JP2010550647A JP2010550647A JP2011514355A5 JP 2011514355 A5 JP2011514355 A5 JP 2011514355A5 JP 2010550647 A JP2010550647 A JP 2010550647A JP 2010550647 A JP2010550647 A JP 2010550647A JP 2011514355 A5 JP2011514355 A5 JP 2011514355A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- patient
- composition
- platinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2008/003405 WO2009113983A1 (en) | 2008-03-14 | 2008-03-14 | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011514355A JP2011514355A (ja) | 2011-05-06 |
| JP2011514355A5 true JP2011514355A5 (https=) | 2011-06-16 |
| JP5694782B2 JP5694782B2 (ja) | 2015-04-01 |
Family
ID=41065492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010550647A Active JP5694782B2 (ja) | 2008-03-14 | 2008-03-14 | 肺癌、腺癌及び他の病状のための治療方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2249825B1 (https=) |
| JP (1) | JP5694782B2 (https=) |
| AU (1) | AU2008352597B2 (https=) |
| CA (1) | CA2717181C (https=) |
| DK (1) | DK2249825T3 (https=) |
| WO (1) | WO2009113983A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11471431B2 (en) * | 2010-09-16 | 2022-10-18 | Lantern Pharma Inc. | Increasing cancer patient survival time by administration of dithio-containing compounds |
| CN109619552A (zh) * | 2018-12-05 | 2019-04-16 | 贾志丹 | 适用于肿瘤患者的营养治疗型配方及制备方法、用途 |
| CN120078760A (zh) * | 2019-03-08 | 2025-06-03 | 蓝腾制药公司 | 治疗患有非小细胞肺癌的女性非吸烟者的方法 |
| CN115040549A (zh) * | 2022-06-07 | 2022-09-13 | 广东特芯生物科技有限公司 | 一种用于肿瘤的组合物 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4177263A (en) | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
| US4657927A (en) | 1978-05-04 | 1987-04-14 | Research Corporation | Malonato platinum compounds |
| US4310515A (en) | 1978-05-30 | 1982-01-12 | Bristol-Myers Company | Pharmaceutical compositions of cisplatin |
| US4302446A (en) | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
| US4451447A (en) | 1980-03-31 | 1984-05-29 | Bristol-Myers Company | Pharmaceutical formulations |
| FR2601675B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4915956A (en) | 1987-12-16 | 1990-04-10 | Lyphomed, Inc. | Liquid cisplatin formulations |
| US5714512A (en) | 1991-07-08 | 1998-02-03 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
| US5698582A (en) | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
| JPH0776230B2 (ja) | 1992-01-13 | 1995-08-16 | 田中貴金属工業株式会社 | 白金化合物の製造方法 |
| JP2673331B2 (ja) | 1993-01-12 | 1997-11-05 | 田中貴金属工業 株式会社 | 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼） |
| CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
| FR2698543B1 (fr) | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| JP3025602B2 (ja) | 1993-05-21 | 2000-03-27 | デビオファーム エス．アー． | 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法 |
| IL114852A (en) | 1994-08-08 | 2000-02-29 | Debiopharm Sa | Pharmaceutically stable preparation of oxaliplatinum |
| US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| US5789000A (en) * | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
| DE19617802A1 (de) | 1996-05-03 | 1997-11-06 | Basf Ag | Verfahren zur heterogen katalysierten Herstellung von Hydroxyalkyl-substituierten Aminoalkinen |
| US6037336A (en) | 1996-09-23 | 2000-03-14 | Bionumerik Pharmaceuticals, Inc. | Reducing toxic effects of carboplatin using dithioethers |
| ES2170414T3 (es) * | 1996-09-23 | 2002-08-01 | Bionumerik Pharmaceuticals Inc | Reduccion de efectos toxicos del carboplatino usando ditioeteres. |
| US6160167A (en) | 1998-04-21 | 2000-12-12 | Bionumerik Pharmaceuticals, Inc. | Mercaptans and disulfides |
| EP1351677A4 (en) * | 2001-01-19 | 2009-08-19 | Bionumerik Pharmaceuticals Inc | CANCER TREATMENT METHOD |
| US6504049B1 (en) | 2002-04-30 | 2003-01-07 | Bionumerik Pharmaceuticals, Inc. | Process for synthesizing pharmaceutically active disulfide salts |
| US8710095B2 (en) * | 2002-04-30 | 2014-04-29 | Bionumerik Pharmaceuticals, Inc. | Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity |
| US20050256055A1 (en) | 2004-05-12 | 2005-11-17 | Hausheer Frederick H | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| EP2004175A4 (en) * | 2006-03-16 | 2010-12-15 | Bionumerik Pharmaceuticals Inc | COMPOUNDS AND FORMULATIONS FOR INCREASING THE EFFECT OF CANCER AND METHOD FOR THEIR USE |
| JP6516187B2 (ja) | 2015-07-23 | 2019-05-22 | パナソニックＩｐマネジメント株式会社 | 眠気判定装置、眠気判定方法、眠気判定プログラムおよび記録媒体 |
-
2008
- 2008-03-14 CA CA2717181A patent/CA2717181C/en active Active
- 2008-03-14 JP JP2010550647A patent/JP5694782B2/ja active Active
- 2008-03-14 WO PCT/US2008/003405 patent/WO2009113983A1/en not_active Ceased
- 2008-03-14 AU AU2008352597A patent/AU2008352597B2/en active Active
- 2008-03-14 EP EP08726839.7A patent/EP2249825B1/en active Active
- 2008-03-14 DK DK08726839.7T patent/DK2249825T3/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2786756B1 (en) | Combination therapy with a topoisomerase inhibitor | |
| RU2587013C2 (ru) | Комбинированная химиотерапия | |
| ES2213922T3 (es) | Formulaciones y metodos para reducir la toxicidad de agentes antineoplasticos. | |
| KR101848131B1 (ko) | 저용량 이리노테칸염산염 수화물을 함유하는 항종양제 | |
| AU2001252442A1 (en) | Combination chemotherapy | |
| WO2010086964A1 (ja) | がん治療のための併用療法 | |
| AU2009215329B2 (en) | Combination comprising paclitaxel for treating ovarian cancer | |
| JP2011514355A5 (https=) | ||
| CA2648945A1 (en) | Chemoprotective methods and compositions | |
| US6355628B1 (en) | Combination therapy using pentafluorobenzenesulfonamides | |
| ES2278702T3 (es) | Composicion para el tratamiento de metastasis o del cancer, que contiene fluorouracilo y un agente de transferencia de metilol. | |
| MXPA04006822A (es) | Combinaciones que comprenden epotilonas y anti-metabolitos. | |
| JP2009292837A (ja) | より効能が大きく副作用の少ない癌治療方法 | |
| US6822001B2 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| RU2284818C2 (ru) | Комбинированная химиотерапия | |
| KR101847252B1 (ko) | 이리노테칸염산염 수화물을 함유하는 항종양제 | |
| JP2011514356A5 (https=) | ||
| HK1202423B (en) | Combination therapy with a topoisomerase inhibitor | |
| NZ740252B2 (en) | Antitumor agent including low-dose irinotecan hydrochloride hydrate | |
| HK1202419B (en) | Combination therapy with a mitotic inhibitor | |
| HK1116409A (en) | Combination chemotherapy | |
| JPWO2009119092A1 (ja) | シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤 | |
| TW201313225A (zh) | 與放射線治療關聯之包含奧瑞布林（ｏｍｂｒａｂｕｌｉｎ）及順鉑（ｃｉｓｐｌａｔｉｎ）之抗腫瘤組合 | |
| NZ740252A (en) | Antitumor agent including low-dose irinotecan hydrochloride hydrate |